Literature DB >> 15041193

A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats.

Ai-Min Zhou1, Wen-Bin Li, Qing-Jun Li, Hui-Qing Liu, Rong-Fang Feng, Hong-Gang Zhao.   

Abstract

Pharmacologically blocking or stimulating studies have showed the crucial role of adenosine receptors in the protective effect of cerebral ischemic preconditioning (CIP). However, little is know about whether the adenosine receptors are up-regulated in the process. In the present study, changes in expression of adenosine receptors in the CA1 hippocampus after a short CIP in a period of 3 min were investigated in rat four-vessel occluding (4VO) brain ischemic model using immunohistochemistry. The experiments were performed on groups of sham, 4 h, 1, 3, and 7 days (n = 6 in each group) after the CIP. The number and immunostaining density of immunoreactive cells for A1 and A2b adenosine receptors in the CA1 hippocampus were significantly increased after the CIP. For A1 adenosine receptor, the increase occurred in CA1 pyramidal neurons. While for A2b adenosine receptor, the increase occurred in the stratum radiatum of the CA1. The immunoreactive cells for A2b receptor showed distinct morphological characteristics of astrocytes. The increases were consistent in time course (1-7 days) with the development of the ischemic tolerance induced by the CIP. It was concluded that up-regulation of adenosine receptors may also play an important role in the protective effect of CIP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041193     DOI: 10.1016/j.neures.2003.12.010

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  17 in total

Review 1.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 2.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

Review 3.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

Review 4.  Signaling pathways leading to ischemic mitochondrial neuroprotection.

Authors:  John W Thompson; Srinivasan V Narayanan; Kevin B Koronowski; Kahlilia Morris-Blanco; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

5.  Neuroprotective potential of exercise preconditioning in stroke.

Authors:  Mohammad Rashedul Islam; Michael F Young; Christiane D Wrann
Journal:  Cond Med       Date:  2017

Review 6.  Cerebral Ischemic Preconditioning: the Road So Far….

Authors:  N Thushara Vijayakumar; Amit Sangwan; Bhargy Sharma; Arshad Majid; G K Rajanikant
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

7.  Nitric oxide participates in the induction of brain ischemic tolerance via activating ERK1/2 signaling pathways.

Authors:  Hui-Qing Liu; Wen-Bin Li; Qing-Jun Li; Min Zhang; Xiao-Cai Sun; Rong-Fang Feng; Xiao-Hui Xian; Shu-Qin Li; Jie Qi; Hong-Gang Zhao
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

8.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

9.  Adenosine neuromodulation and traumatic brain injury.

Authors:  T A Lusardi
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  The neuroprotective mechanism of brain ischemic preconditioning.

Authors:  Xiao-qian Liu; Rui Sheng; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.